Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells

doi:10.1016/j.jmii.2021.03.007

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 生物科技系(所) > 期刊論文 > Item 310902800/34348

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34348

標題:	Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells
作者:	Wu, Yen-Hung Yeh, I-Jeng Phan, Nam Nhut Yen, Meng-Chi Hung, Jui-Hsiang Chiao, Chung-Chieh Chen, Chien-Fu Sun, Zhengda Hsu, Hui-Ping Wang, Chih-Yang Lai, Ming-Derg
貢獻者:	Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Emergency Med Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med Nguyen Tat Thanh Univ, NTT Inst Hitechnol Chia Nan Univ Pharm & Sci, Dept Biotechnol I Shou Univ, Sch Chinese Med Postbaccalaureate Kaiser Permanente, Northern Calif Reg Labs, Permanente Med Grp Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Surg Vanderbilt Univ, Dept Biostat, Med Ctr Taipei Med Univ, Coll Med Sci & Technol, PhD Program Canc Mol Biol & Drug Discovery Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery Natl Cheng Kung Univ, Dept Biochem & Mol Biol Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci
關鍵字:	Coronavirus Middle East respiratory syndrome coronavirus (MERS-CoV) miRNA Bioinformatics Connectivity map Lung adenocarcinoma
日期:	2021
上傳時間:	2023-11-11 11:45:00 (UTC+8)
出版者:	ELSEVIER TAIWAN
摘要:	Background: Pathogenic coronaviruses include Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), and SARS-CoV-2. These viruses have induced outbreaks worldwide, and there are currently no effective medications against them. Therefore, there is an urgent need to develop potential drugs against coronaviruses. Methods: High-throughput technology is widely used to explore differences in messenger (m) RNA and micro (mi)RNA expression profiles, especially to investigate proteineprotein interactions and search for new therapeutic compounds. We integrated miRNA and mRNA expression profiles in MERS-CoV-infected cells and compared them to mock-infected controls from public databases. Results: Through the bioinformatics analysis, there were 251 upregulated genes and eight highly differentiated miRNAs that overlapped in the two datasets. External validation verified that these genes had high expression in MERS-CoV-infected cells, including RC3H1, NF-kappa B, CD69, TNFAIP3, LEAP-2, DUSP10, CREB5, CXCL2, etc. We revealed that immune, olfactory or sensory system-related, and signal-transduction networks were discovered from upregulated mRNAs in MERS-CoV-infected cells. In total, 115 genes were predicted to be related to miRNAs, with the intersection of upregulated mRNAs and miRNA-targeting prediction genes such as TCF4, NR3C1, and POU2F2. Through the Connectivity Map (CMap) platform, we suggested potential compounds to use against MERS-CoV infection, including diethylcarbamazine, harpagoside, bumetanide, enalapril, and valproic acid. Conclusions: The present study illustrates the crucial roles of miRNA- mRNA interacting networks in MERS-CoV-infected cells. The genes we identified are potential targets for treating MERS-CoV infection; however, these could possibly be extended to other coronavirus infections. Copyright (C) 2021, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
關聯:	J MICROBIOL IMMUNOL, v.54, n.5, pp.845-857
顯示於類別:	[生物科技系(所)] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	217	檢視/開啟
j.jmii.2021.03.007.pdf		3716Kb	Adobe PDF	90	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....